Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Oct 08, 2022 3:40 PM - Oct 09, 2022 12:10 AM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

DIA Asia Meeting 2022

Digital Transformation in Clinical Development and Product Information

SESSION 3 : New Era for Product Information in Digital Health and Pharmacovigilance

Session Chair(s)

Shun  Jin, MBA

Shun Jin, MBA

Head, Regulatory Affairs, APMA

Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore

Rie  Matsui, RPh

Rie Matsui, RPh

Senior Director, Regional Labeling Head for APAC, International Labeling

Pfizer R&D Japan G.K., Japan

Speaker(s)

Craig  Anderson

New Era for Product Information in Digital Health and Pharmacovigilance: FHIR and Electronic Product Information (ePI)

Craig Anderson

Pfizer Inc , Canada

Director, International Labeling

Anne  Moen, PhD, MSc, RN

Gravitate – Health ePI on FHIR in EU and beyond

Anne Moen, PhD, MSc, RN

University of Oslo, Norway

Professor, Faculty of Medicine, Coordinator, Gravitate-Health

Yoshihiro  Aoyagi, MS

Current and Future e-labeling in Japan ~Considering Interoperability (HL7 FHIR) from a Health Care Professional Perspective ~

Yoshihiro Aoyagi, MS

National Cancer Center Hospital East, Japan

Manager, Department of Medical Information

Arisa  Toyoda

Digital health and product information in Japan

Arisa Toyoda

Ministry of Health, Labour and Welfare, Japan

Pharmaceutical Safety Division, Pharmaceutical Safety

Yuan  Meng

Updates for Pharmacovigilance initiatives in China

Yuan Meng

I-Mab Biopharma , China

Head of Medical Office R&D

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.